Atlanta Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $141M | Sell |
|
|||||
|
2020
Q3 | $205M | Sell |
|
|||||
|
2020
Q2 | $204M | Sell |
|
|||||
|
2020
Q1 | $160M | Sell |
|
|||||
|
2019
Q4 | $277M | Sell |
|
|||||
|
2019
Q3 | $251M | Sell |
|
|||||
|
2019
Q2 | $236M | Buy |
|
|||||
|
2019
Q1 | $229M | Buy |
|
|||||
|
2018
Q4 | $174M | Sell |
|
|||||
|
2018
Q3 | $413M | Sell |
|
|||||
|
2018
Q2 | $422M | Sell |
|
|||||
|
2018
Q1 | $368M | Sell |
|
|||||
|
2017
Q4 | $352M | Sell |
|
|||||
|
2017
Q3 | $350M | Sell |
|
|||||
|
2017
Q2 | $373M | Sell |
|
|||||
|
2017
Q1 | $350M | Sell |
|
|||||
|
2016
Q4 | $325M | Sell |
|
|||||
|
2016
Q3 | $294M | Buy |
|
|||||
|
2016
Q2 | $253M | Buy |
|
|||||
|
2016
Q1 | $236M | Sell |
|
|||||
|
2015
Q4 | $241M | Sell |
|
|||||
|
2015
Q3 | $234M | Buy |
|
|||||
|
2015
Q2 | $262M | Sell |
|
|||||
|
2015
Q1 | $242M | Sell |
|
|||||
|
2014
Q4 | $218M | Sell |
|
|||||
|
2014
Q3 | $207M | Sell |
|
|||||
|
2014
Q2 | $220M | Buy |
|
|||||
|
2014
Q1 | $231M | Sell |
|
|||||
|
2013
Q4 | $224M | Buy |
|
|||||
|
2013
Q3 | $201M | Buy |
|
|||||
|
2013
Q2 | $192M | Buy |
|